Programme (Day 1: 7 Nov)

Download Programme

09:00 – 10:30 Session 1 (Physics)
Moderator: Martin Bues
Physics of Particle Therapy
...

Hsiao-ming Lu

Director of Physics and Technology
Hefei Ion Medical Center
China

Hsiao-Ming Lu, PhD. is an ABR certified clinical physicist and a fellow of Association of American Physicist in Medicine. He has been working in the field of proton therapy physics since 2003 and served as the Director of Clinical Physics in the Department of Radiation Oncology at Massachusetts General Hospital, Harvard Medical School, Boston, before he returned to China in 2019. He is now the Director of Physics at Hefei Ion Medical Center, Anhui Provincial Hospital, Chinese University of Science and Technology, Hefei, China.

Hsiaoming Lu (China)
Clinical Commissioning of Proton Therapy Systems: Practical Considerations
Zuofeng Li (China)
Uncertainties and Their Management in Proton Therapy
Young-yih Han (Korea)
10:30 – 11:00 Coffee Break, Exhibition and e-Poster Viewing
11:00 – 13:00 Session 2 (Physics)
Moderators: Young-yi Han and Dayananda Sharma
Shielding Design of PT Facility - HKSH Experience
Kin-yin Cheung (Hong Kong, China)
Proton Therapy Dosimetry
Hong-qi Tan (Singapore)
Patient Specific QA in Proton Therapy
Hsiao-chieh Huang (Taiwan)
Quality Assurance of Proton Therapy System
...

Mintra Keawsamur

Lecturer
Department of Radiology, Faculty of Medicine
Chulalongkorn University, Thailand

Dr. Mintra currently serves as a lecturer at Chulalongkorn University, where she teaches both undergraduate and graduate programs in radiological technology and medical physics. She has over a decade of experience working as a medical physicist at King Chulalongkorn Memorial Hospital and has participated in training programs at renowned international institutions, including the Paul Scherrer Institut (Switzerland) and the National Centre of Oncological Hadrontherapy (Italy).

Her research interests include proton therapy, brachytherapy, and dosimetry, with several ongoing projects aimed at developing treatment guidelines and quality assurance protocols. She has received multiple accolades, such as the Young Leaders Award 2022 from SEAFOMP and the Excellence Award in the Radiation Oncology Medical Physics (ROMP) training program.

Dr. Mintra is also an active member of professional organizations, including the Thai Medical Physics Society and PTCOG-AO, and has authored numerous scientific publications and book chapters in the field of radiotherapy.

Mintra Keawsamur (Thailand)
13:00 – 14:00 Lunch Symposium 1
(Sponsored by Siemens Healthcare Limited & Varian Medical Systems Pacific, Inc.)
Topic TBC
14:00 – 16:00 Session 3 (Clinical)
Moderators: Kanjana Shotelersuk and Chun-chung Yau
Proton versus Photon Radiotherapy for Head and Neck Cancer –
The Journey to a New Standard of Care

...

Steven J. Frank

Executive Director, Particle Therapy Institute
Department of Radiation Oncology, Division of Radiation Oncology
The University of Texas MD Anderson Cancer Center
USA

Steven J. Frank, MD, is an endowed tenured professor of Radiation Oncology, holds the Bessie McGoldrick Professorship in Clinical Research, and is a fellow of the ABS, ACR, and ASTRO. Dr. Frank is the Executive Director of the Particle Therapy Institute and Deputy Head of Strategy for the Division of Radiation Oncology. Dr. Frank is amongst the first, if not the first, to use IMPT to treat head and neck tumors, and he is the Principal Investigator of an NIH/NCI/Hitachi-sponsored multi-institutional Phase II/III randomized trial in advanced stage oropharyngeal cancer that compares outcomes after chemoradiation given by IMRT versus IMPT.

Dr. Frank has over 300 peer-reviewed publications, has authored many book chapters and has recently published the first textbook on Proton Therapy. Dr. Frank's lab is studying the biologic enhancement factor of proton therapy and FLASH radiotherapy for both head and neck and prostate cancer, as well as MRI-Assisted Radiosurgery (MARS) as the next generation of prostate brachytherapy. Dr. Frank's expertise in MRI radiotherapy has led to the development and FDA approval of multiple novel positive-contrast implantable markers for use in MRI-guided LDR and HDR prostate brachytherapy and external beam radiation therapy.

As founder of the company, C4 Imaging, Dr. Frank has developed the MRI marker technology at MD Anderson, has been granted 31 national and international patents, developed three FDA-approved products and has established MRI-Assisted Radiosurgery (MARS) at MD Anderson for the treatment of prostate cancer. He has funding from the NIH, the Prostate Cancer Foundation, the Texas Ignition Fund, Hitachi and MD Anderson, and he has also raised multiple rounds of private equity financing to advance the C4 technology. Dr. Frank has served as the past President and Chairman of the Board of the American Brachytherapy Society and is the 2023 recipient of the Ulrich Henschke Award, the highest honor awarded by the ABS on a practitioner of brachytherapy.

Dr. Frank has served as the chair for the head and neck oral boards for seven years and is currently serving on the Radiation Oncology Board of Trustees for the American Board of Radiology.

Steven Frank (USA)
Breast
...

Lisa McGee

Radiation Oncologist
Department of Radiation Oncology
Mayo Clinic Arizona
USA

Dr. McGee is a Radiation Oncologist and Assistant Professor on staff at the Mayo Clinic in Arizona. Her disease-site interests include breast cancer as well as head and neck malignancies with a focus in proton therapy. She is also active in education, serving as Residency Program Director at the Mayo Clinic in Arizona amongst other educational roles.

Lisa McGee (USA)
Central Nervous System
...

Damien Weber

Head and Chairman
Center for Proton Therapy
Paul Scherrer Institute PSI
Switzerland

Damien Charles Weber has been Head and Chairman of the Center for Proton Therapy at the Paul Scherrer Institute since 2013. He has currently a faculty position both at the University of Zürich and Bern. He trained as a radiation oncologist at the University Hospital of Geneva and was a clinical and research fellow at the General Massachusetts Hospital/Harvard Medical School, after which he worked at PSI when coming back to Switzerland.

His domain of expertise is Neuro-Oncology for adults and pediatric patients and has been past Chair both for the Radiation Oncology Group of the European Organization for the Research and Treatment of Cancer and for the Swiss Association for the Research in Radiation Oncology.

He is currently the Co-Chairman of the European Particle Therapy Network (European Society of RadioTherapy and Oncology; ESTRO) and member of ESTRO's Scientific Council. He is also a member of the research council of the Swiss Pediatric Oncology Group.

Damien Weber (USA)
16:00 – 16:30 Coffee Break, Exhibition and e-Poster Viewing
16:30 – 18:00 Session 4 (Clinical)
Moderators: Tae-hyun Kim and Henry Chun-kin Sze
Gastrointestinal Oncology
...

Terence Tai-weng Sio

Professor of Radiation Oncology
Department of Radiation Oncology
Mayo Clinic Arizona, Phoenix, AZ
USA

Terence T. Sio, M.D., M.S., is Professor of Radiation Oncology and radiation oncologist who specializes in both X-ray based and proton radiotherapies. His main focuses are in gastrointestinal, lung, and brain cancers including brain metastasis treatments using stereotactic radiosurgery (SRS). He has a strong interest in ion beam radiotherapies internationally

Terence Tai-weng Sio (USA)
Proton Beam Therapy for Genitourinary Cancers
...

Jeffrey Kit-loong Tuan

Head
Department of Gastrointestinal Hepato-pancreato-biliary and
Urology Division of Radiation Oncology
National Cancer Centre Singapore
Singapore

Clinical Associate Professor Jeffrey Tuan is the Head and Senior Consultant Radiation Oncologist in the Department of Hepato-Pancreato-Biliary, Gastrointestinal, and Genitourinary Radiation Oncology in the Division of Radiation Oncology at the National Cancer Centre Singapore (NCCS). He is also a Clinical Associate Professor in Oncology Academic Program (ACP) of the Duke-NUS medical school. He graduated from the National University of Singapore (NUS) and holds a Master of Science in Oncology from the University of London. He is a fellow of the Royal College of Radiologists (RCR), United Kingdom and honorary secretary of the College of Radiologists (CRS), Academy of Medicine Singapore (AMS).

His clinical interests are in urological and gynaecological cancers and advanced radiation therapy techniques e.g. volumetric modulated arc therapy, stereotactic body radiotherapy, and brachytherapy. He was involved in the setup of the new proton beam therapy centre located in the National Cancer Centre Singapore opened in 2023.

Jeffrey Kit-loong Tuan (Singapore)
Paediatric Non-Central Nervous System
Michael Kam (Hong Kong, China)